A Study of the Safety and Effectiveness of Simeprevir and Sofosbuvir for Patients With HIV and Hepatitis C
Status:
Withdrawn
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
This is a study of the safety and effectiveness of the hepatitis C medications sofosbuvir and
simeprevir in patients who have both the HIV and hepatitis C (HCV) viruses.